Price erosion in US generics
Management acknowledged price erosion on select large products, partially offset by other products. Continued erosion could pressure US margins.
medium · management_commentary
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Forex volatility in emerging markets
Emerging market growth in constant currency may be offset by unfavorable forex movements, particularly in Russia and other markets.
medium · management_commentaryBiosimilar Rituximab CRL delays
US FDA issued a complete response letter for biosimilar Rituximab due to CMC questions; resolution expected around September, but timeline for approval remains uncertain.
high · analyst_questionCompetition in Revlimid generic
Multiple new entrants in the generic Revlimid market could impact pricing and volume, though management declined to discuss specifics.
medium · analyst_question